APA-viite

Tuerksever, C., Pruente, C., & Hatz, K. (2021). High frequency SD-OCT follow-up leading to up to biweekly intravitreal ranibizumab treatment in neovascular age-related macular degeneration. Sci Rep.

Chicago-tyylinen lähdeviittaus

Tuerksever, Cengiz, Christian Pruente, ja Katja Hatz. "High Frequency SD-OCT Follow-up Leading to Up to Biweekly Intravitreal Ranibizumab Treatment in Neovascular Age-related Macular Degeneration." Sci Rep 2021.

MLA-viite

Tuerksever, Cengiz, Christian Pruente, ja Katja Hatz. "High Frequency SD-OCT Follow-up Leading to Up to Biweekly Intravitreal Ranibizumab Treatment in Neovascular Age-related Macular Degeneration." Sci Rep 2021.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.